Edition:
United States

Melinta Therapeutics Inc (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

1.02USD
18 Jan 2019
Change (% chg)

$0.04 (+3.96%)
Prev Close
$0.98
Open
$0.99
Day's High
$1.03
Day's Low
$0.98
Volume
68,682
Avg. Vol
129,925
52-wk High
$15.20
52-wk Low
$0.64

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.84 December 19 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 4 4 3
(3) HOLD 3 2 2 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.14 2.00 2.00 2.12

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 16.80 16.80 16.80 --
Quarter Ending Jun-19 1 18.20 18.20 18.20 --
Year Ending Dec-19 5 92.26 137.80 72.90 103.00
Earnings (per share)
Quarter Ending Mar-19 1 -0.84 -0.84 -0.84 --
Quarter Ending Jun-19 1 -0.74 -0.74 -0.74 --
Year Ending Dec-19 5 -2.09 -1.40 -2.91 -4.70

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 16.58 34.08 17.50 105.54
Quarter Ending Jun-18 13.40 12.02 1.38 10.28
Quarter Ending Mar-18 12.92 14.84 1.92 14.86
Quarter Ending Dec-17 3.89 4.23 0.34 8.79
Quarter Ending Sep-17 2.22 1.72 0.51 22.80
Earnings (per share)
Quarter Ending Sep-18 -0.94 -0.40 0.54 -57.26
Quarter Ending Jun-18 -1.14 -1.38 0.24 -21.40
Quarter Ending Mar-18 -1.30 -1.53 0.23 -17.62
Quarter Ending Dec-17 -0.76 -1.48 0.72 -95.59
Quarter Ending Sep-17 -0.78 -1.00 0.22 -27.67

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 16.80 16.80 -- -- --
Quarter Ending Jun-19 18.20 18.20 -- -- --
Year Ending Dec-19 92.26 92.26 88.57 99.83 103.00
Earnings (per share)
Quarter Ending Mar-19 -0.84 -0.84 -- -0.54 --
Quarter Ending Jun-19 -0.74 -0.74 -- -0.51 --
Year Ending Dec-19 -2.09 -2.09 -1.79 -2.62 -4.70

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 -- --
Quarter Ending Jun-19 0 0 -- --
Year Ending Dec-19 0 0 0 2
Earnings
Quarter Ending Mar-19 0 0 -- --
Quarter Ending Jun-19 0 0 -- --
Year Ending Dec-19 0 0 1 2